Following the approval of Toripalimab by the Food and Drug Administration, two more Chinese-made cancer drugs have received approval for distribution in the US.
Maybe discredit the source, then? The commenter did no work to demonstrate that the statements claimed in the article were illegitimate. It should be trivial, given that the article (and myself) cites an SEC report.
Maybe discredit the source, then? The commenter did no work to demonstrate that the statements claimed in the article were illegitimate. It should be trivial, given that the article (and myself) cites an SEC report.